首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical Observation on Shuanghuanglian powder in treating viral myocarditis of childrenin treating viral myocarditis of children
Authors:Guozhen Lin  Dongmei Liu  Lin Zhu  Dingzhong Qiu
Affiliation:(1) Affiliated Ruijin Hospital of Shanghai Second Medical University, (200025) Shanghai
Abstract:Objective: To study immune function of children viral myocarditis and to evaluate the clinical effect of Shuanghuanglian Powder (SHLP) by injection.Methods: The 62 patients of viral myocarditis were divided into two groups randomly, the SHLP group (n = 32) treated with conventional therapy plus SHLP and the conventional treatment group (n = 30) with conventional therapy alone. Their serum antibody of Coxsackie virus group B (COXB-IgM), T-lymphocyte subsets including CD3 +, CD4 +, CD8 + and CD4 +/CD8 + were determined with ELISA and indirect immunofluorescent assay.Results: COXB-IgM was positive in 39 of the 62 patients, which was significantly different with those of normal controls (P< 0.001). Patients’ serum level of CD4 + cells and CD4 +/CD8 + ratio decreased while CD8 + increased. After treatment, the recovery of symptoms, signs and immune function in patients of the SHLP group were significantly better than those in patients treated with conventional treatment alone (P<0.01).Conclusion: Immunoregulatory disturbance is involved in children with viral myocarditis and SHLP is an effective drug in the treatment of children viral myocarditis.
Keywords:Shuanghuanglian Powder  infantile viral myocarditis  T-lymphocyte subset  Coxsackievirus group B antibody
本文献已被 SpringerLink 等数据库收录!
点击此处可从《中国结合医学杂志》浏览原始摘要信息
点击此处可从《中国结合医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号